Table 1.

Characteristics of Wilson disease patients

	Sex	Age at diagnosis (years old)	Familiar history	Predominant features	Neurologic symptoms	Kayser–Fleischer rings	Staging of liver fibrosis (Metavir score)	Hepatic liver failure	Treatment	Liver transplant	Outcome	Follow-up (years)
1	Male	18	No	Hepatic	No	No	F4	No	Penicillamine	No	Alive	29
2	Male	22	No	Neuropsychiatric	Yes	Yes	F3	No	Penicillamine >> Trientin	No	Alive	4
3	Male	43	No	Hepatic	No	No	F4	No	Trientin	No	Alive	4
4	Female	15	No	Hepatic	No	No	F1	No	Zinc	No	Alive	25
5	Female	12	No	Hepatic	No	No	F2	No	Penicillamine	No	Alive	8
6	Male	30	No	Hepatic	No	Yes	F4	No	Penicillamine	Yes	Alive	20
7	Female	8	No	Hepatic	No	No	F2	No	Trientin	No	Alive	14
8	Female	13	Yes	Neuropsychiatric	Yes	Yes	F4	Yes	–	Yes	Alive	15
9	Female	16	No	Hepatic	No	No	F4	No	–	Yes	Alive	29
10	Male	22	Yes	Hepatic	No	Yes	F4	No	–	Yes	Alive	14
11	Male	18	No	Ophthalmologic	No	Yes	F1	No	Penicillamine	No	Alive	32
12	Male	25	No	Neuropsychiatric	Yes	Yes	F4	No	–	Yes	Alive	20
13	Female	25	No	Neuropsychiatric	Yes	Yes	F4	No	Penicillamine	No	Death	12
14	Male	8	No	Hepatic	No	No	F1	No	Trientin	No	Alive	18
15	Male	18	Yes	Hepatic	No	No	F4	No	Penicillamine >> Trientin	No	Alive	17
16	Male	9	Yes	Hepatic	No	Yes	F4	No	Penicillamine	No	Alive	18
17	Male	22	No	Hepatic	No	Yes	F4	Yes	–	Yes	Alive	22
18	Female	50	No	Hepatic	No	No	F2	No	Penicillamine >> Trientin	No	Alive	15
19	Female	18	No	Hepatic	No	Yes	F4	Yes	–	Yes	Alive	22
20	Male	25	No	Neuropsychiatric	Yes	Yes	F4	No	–	Yes	Death	7
21	Female	16	No	Neuropsychiatric	Yes	Yes	F4	No	Penicillamine	Yes	Alive	19
22	Female	19	No	Hepatic	Yes	Yes	F4	Yes	–	Yes	Alive	16
23	Male	21	Yes	Hepatic	Yes	No	F2	No	Trientin	No	Alive	20
24	Female	32	No	Hepatic	No	No	F2	No	Penicillamine >> Trientin	No	Alive	20